Maruho Report 2023

10/60

Maruho Report 20239ProductProductProviding informationProductMarchReleased new video on “What’s Herpes?,” a general information website on herpes treatmentMarchLaunched sunscreen serum iniks Advanced Barrier Day Essencep. 29LicensingProductMayReleased new video on “Underarm Sweat Clear Project,” our general information website on underarm sweat treatmentMayLaunched BEPIO Lotion, an acne vulgaris treatment agentpp. 23–24Providing informationProduct1. Maruho’s Meaning of Existence Main Topics in the Fiscal Year Ended September 2023Maruho is focusing on the expansion of its lineup of new products and the provision of information to patients. In the fiscal year ended September 2023, we contributed to society through continuously providing information on pharmaceuticals and diseases.FebruaryAcquired additional approval of recurrent herpes simplex for anti-herpes virus agent Amenalief Tabletspp. 23–24FebruaryLaunched herpes simplex detection kit DermaQuick HSVp. 29AprilEntered into a license agreement to market a treatment for common warts in Japanpp. 23–24AprilLaunched Renail Gel, a treatment agent for pincer nailspp. 23–24Addressing skin concerns through multifaceted activities